Product Images Glimepiride
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Glimepiride NDC 50268-358 by Avpak, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
358 - 358 15
This is a description of Glimebiride tablets. It is a prescription medication that comes in a unit dose package of 50 tablets. The recommended dose is one tablet once a day. The available dosage is 1mg. The manufacturer warns to keep the medication out of reach of children. The manufacturer is AARE Inc, located in Pkasd TN.*
359 - 359 15
Glimepiride is a medication that comes in the form of tablets and requires a prescription. Each tablet contains 2mg of glimepiride and the package consists of 50 tablets, which are divided into five unit doses of 10 tablets each. The recommended dosage and administration instructions vary and can be found on the packaging. It is a warning that this medication should not be within the reach of children. The package contains essential information and includes a registration number. It is produced by Aare Inc. located in Plaisd, TN.*
360 - 360 15
This is a package of Glimepiride Tablets, USP, with a strength of 4mg, containing 50 tablets in total. The package has five unit doses of tablets. The recommended dosage is detailed in the packaging and it is only available under a prescription. There is a warning to keep the medication out of reach of children. The package is not for sale separately and must be kept in a cool and dry place. The product is made by AvKare.*
structure - structure
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.